Skip to main content
Clinical Trials/JPRN-UMIN000013517
JPRN-UMIN000013517
Completed
未知

PET study of brain tau deposition in traumatic brain injury using [11C]PBB3 - PET study of brain tau deposition in traumatic brain injury using [11C]PBB3

ational Institute of Radiological Sciences0 sites32 target enrollmentApril 1, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy volunteer, Traumatic brain injury (TBI)
Sponsor
ational Institute of Radiological Sciences
Enrollment
32
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2014
End Date
December 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Institute of Radiological Sciences

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • I. Patients 1\. Subjects without ability to make informed consent 2\. Subjects with any psychiatric disorder not due to TBI 3\. Subjects with any organic brain disorder not due to TBI 4\. Subjects with severe physical complication 5\. Subjects with severe claustrophobia 6\. Pregnant women 7\. Subjects with tattoo 8\. Subjects with metallic medical device in the body 9\. Subjects who was considered to be inappropriate to participate in the study II. Healthy volunteers 1\. Subjects without ability to make informed consent 2\. Subjects with any psychiatric disorder 3\. Subjects with any organic brain disorder 4\. Subjects with severe physical complication 5\. Subjects with severe claustrophobia 6\. Subjects who has participated in other study in recent 6 months. 7\. Pregnant women 8\. Subjects with tattoo 9\. Subjects with metallic medical device in the body 10\. Subjects who was considered to be inappropriate to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
PET imaging study of the brain tau deposit in individuals with subjective cognitivedecline and mild cognitive impairment: FACEHBI cohort.Subjective cognitive impairment and mild cognitive decline in evaluation fordiagnosis of Alzheimer's Disease.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2021-000473-83-ESFundació ACE-Institut Català de Neurociències Aplicades100
Completed
Not Applicable
PET study of brain tau deposition in late onset psychosis using [11C]PBB3
JPRN-UMIN000017837ational Institute of Radiological Sciences57
Recruiting
Not Applicable
[18F]THK-5351 PET imaging of tau deposits in neurological disorderscorticobasal syndrome, other neurodegenerative disorders, and normal volunteers
JPRN-UMIN000021819Tohoku University160
Not yet recruiting
Not Applicable
Traumatic brain injury and Tau pathologyTraumatic brain injury
JPRN-UMIN000041868Kyoto University30
Completed
Not Applicable
Mapping of brain tau deposition in tauopathy by PET with [11C]PBB3Healthy volunteers 20 years of age or older at the time of obtaining consent Patients with mild cognitive impairment (MCI) 20 years of age or older at the time of obtaining consent Patients with Alzheimer&#39s disease (AD) 20 years of age or older at the time of obtaining consent Patients with corticobasal degeneration (CBD) 20 years of age or older at the time of obtaining consent Patients with progressive supranuclear palsy (PSP) 20 years of age or older at the time of obtaining consent Patients with frontotemporal dementia (FTD) 20 years of age or older at the time of obtaining consent Patients with familial Parkinson&#39s disease with the LRRK2 genetic mutation (PARK8)
JPRN-UMIN000009863ational Institute of Radiological Sciences124